Use of melanotan I and II in the general population

BMJ. 2009 Feb 17:338:b566. doi: 10.1136/bmj.b566.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Male
  • Nonprescription Drugs* / administration & dosage
  • Nonprescription Drugs* / adverse effects
  • Penile Erection / drug effects
  • Peptides, Cyclic* / administration & dosage
  • Peptides, Cyclic* / adverse effects
  • Substance-Related Disorders / etiology*
  • Suntan / drug effects*
  • alpha-MSH / administration & dosage
  • alpha-MSH / adverse effects
  • alpha-MSH / analogs & derivatives*

Substances

  • Nonprescription Drugs
  • Peptides, Cyclic
  • melanotan-II
  • alpha-MSH
  • MSH, 4-Nle-7-Phe-alpha-